---
title: "Ascentage Pharma: Revenue up 29% YoY to $44.5M, with global trial progress and strengthened leadership"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296439099.md"
description: "Revenue rose 29% YoY to $44.5M in 1H 2026, with strong commercial execution and a cash runway through 2027. Key assets Lisaftoclax and Olverembatinib advanced in global Phase III trials, while new leadership appointments support global expansion.Original document: Ascentage Pharma Group International [6855] Slides Release — Aug. 20 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-08-20T05:32:17.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296439099.md)
  - [en](https://longbridge.com/en/news/296439099.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296439099.md)
generator: "portal-rs"
---

# Ascentage Pharma: Revenue up 29% YoY to $44.5M, with global trial progress and strengthened leadership

Revenue rose 29% YoY to $44.5M in 1H 2026, with strong commercial execution and a cash runway through 2027. Key assets Lisaftoclax and Olverembatinib advanced in global Phase III trials, while new leadership appointments support global expansion.

Original document: Ascentage Pharma Group International \[6855\] Slides Release — Aug. 20 2026

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [AAPG.US](https://longbridge.com/en/quote/AAPG.US.md)
- [06855.HK](https://longbridge.com/en/quote/06855.HK.md)
- [AAPGV.US](https://longbridge.com/en/quote/AAPGV.US.md)

## Related News & Research

- [Ascentage Pharma Reports 2026 Interim Unaudited Financial Results and Provides Business Updates | AAPG Stock News](https://longbridge.com/en/news/296408912.md)
- [Ascentage Pharma posts interim results presentation on 1H 2026 business update](https://longbridge.com/en/news/296418315.md)
- [ASCENTAGE  1H26 Loss Widens to RMB817 million; No Interim Dividend](https://longbridge.com/en/news/296423848.md)
- [Walmart store workers have a new responsibility: correcting AI errors](https://longbridge.com/en/news/296213777.md)
- [88% of Nvidia's portfolio is invested in these 3 artificial intelligence (AI) stocks](https://longbridge.com/en/news/296341788.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**